Hikers sitting on a mountaintop overlooking a vast plain

Empowering Healthier Lives

We believe that fast, accurate point of care testing empowers people to enjoy healthier, more informed lives.

Consumers are embracing the power of at-home diagnostics and telehealth.

The Opportunity

This is a pivotal moment in healthcare. Increased consumer acceptance of telemedicine and the need for faster information has generated even greater demand for rapid point of care diagnostics.

Atomo has developed the most consumer friendly platform available for blood-based rapid at-home testing. Our integrated testing technology helps revolutionize access to healthcare solutions and deliver improved healthcare outcomes. We are a world leader in rapid testing solution that puts the user in the center of the testing experience.

Our technology, which is easy to use, safe, reliable, and intuitive, is uniquely positioned to support the growing demand for affordable point of care monitoring of health and at-home testing.

Man and woman sitting at desk looking at diagnostic test design on computer screen

Our Story

After ten years as a senior leader in the medical device sector, Atomo’s Founder and CEO John Kelly identified multiple ways in which diagnostics were ripe for transformation. John observed that usability, convenience, and simplicity of use could make a real difference in diagnostics. When people can’t use a product the way it is intended, the performance is undermined.

While John was exploring areas of the market where usability was poorly delivered, his youngest daughter was born and required intensive medical care for the first two years of her life. He watched as doctors struggled to collect blood from her arm. When John found out that the blood test they were doing only required a tiny drop of blood, he had a light bulb moment. John decided to develop a better, less invasive way to collect a blood sample.

Vision & Mission

Empowering people to enjoy healthier, more informed lives through fast, accurate point of care testing. We are re-imagining diagnostics by putting the user experience at the center of everything we do. Atomo's mission is to ensure equitable and affordable access to accurate diagnoses and promote a seamless pathway to treatment.

Values

Drawing of 4 arrows each at 45 degrees pointing at one another in a diamond formation

Impact

Commercialising products that matter to our users

Drawing of a lightbulb with a gear inside it

Innovation

Fostering creative thinking and solutions

Drawing of a shield with a heart inside

Integrity

Ensuring honesty and fairness in all that we do

Drawing of 3 people icons in a triangle formation connected with curved dotted lines

Collaboration

Working as one
global team

Drawing of 3 5-sided stars in arrow formation

Excellence

Being recognised as experts in the field

Executive Team

Professional photo shoot of man in black and white

John Kelly

Founder, Managing Director & CEO

For more than 20 years John Kelly has championed the cause of reimagining medical devices to enhance their usability and performance. Before founding Atomo Diagnostics in 2010, John was Chief Operating Officer at ASX listed (now NASDAQ listed) Unilife Corporation, where he led the ‘Unifill’ development team to develop the world’s first glass prefilled drug delivery device with integrated auto retract safety feature. This technology was successfully licensed to Sanofi Aventis. Previously, John led the New Product Implementation Group at ResMed, where he managed the design and commercialization of the ground-breaking Mirage Swift mask. In addition to his commercial experience, John has an Honours Degree in Mechanical Engineering from the University of Liverpool, a Master’s Degree in Systems Engineering from Queen’s University Belfast, and an Executive MBA from the University of Sydney, where he was awarded the Business School’s inaugural ‘Excellence in Leadership’ scholarship.

Professional photo shoot of man in black and white

Will Souter

Chief Financial Officer

Experienced senior finance executive, lawyer and investment banker. Most recently Will was Chief Financial Officer for property and construction tech company, Verton Technologies. Previously Executive Director at RFC Ambrian where for 11 years he worked closely with companies on fundraising, public markets listings and M&A. Prior to RFC, Will was a Director at PwC over a 10 year period in London and Sydney, and worked at Minter Ellison Lawyers. Graduate of the AICD, admitted to the Supreme Court of NSW. He holds a Bachelor of Laws, and a Bachelor of Commerce from the University of Adelaide.

Professional photo shoot of woman in black and white

Chandra Sukumar

Chief Operating Officer

Chandra joined Atomo in 2017 as Director of Programs bringing with her more than 25 years of experience within the medical device industry. She has extensive experience in the development of medical devices from conception to commercialisation. Prior to joining Atomo, she served in a variety of leadership roles within ResMed, including supply chain management, global manufacturing, and APAC marketing. Chandra holds a Bachelors Honours degree in Physics and an executive MBA from AGSM.

Board of Directors

Professional photo shoot of man in black and white

John Keith

Non-Executive Chair

John is the Managing Director of BNP Paribas. Prior to that, he led management and coverage roles for Nomura Securities in Sydney and Hong Kong. John also serves as a Director of ASIA Limited, Calliva Limited, Room to Read Australia Foundation and Ascham Foundation.

Professional photo shoot of man in black and white

Dr. Curt LaBelle

Non-Executive Director

Dr. LaBelle has been actively involved in the healthcare industry for 20 years, both operationally and as an investor. He is the Managing Partner at the Global Health Investment Fund, a social impact investment fund, which manages approximately US$108 million backed by the Gates Foundation, JP Morgan and others. He also serves as a director on the boards of Alydia Health, Atticus Medical and Eyenovia. Prior to joining GHIF, Dr. LaBelle was Managing Director at Tullis Health Investors and Vice President at Investor Growth Capital. He also served as chair on the boards of Exagen Inc. (NASDAQ:XGN) and Impulse Monitoring (acquired by Nuvasive) and as a director on the boards of Sirion Therapeutics, SafeOp Surgical (acquired by AlphaTec) and KAI Pharmaceuticals (acquired by Amgen).

Professional photo shoot of man in black and white

Dr. Paul Kasian

Non-Executive Director

Chair of IODM Limited. Non-Executive Director of Eco Systems Ltd (ASX:ESL). Previously Chair and CEO of Genetic Technologies Limited. PhD in Microbiology and MBA, both from the University of Melbourne, and GAICD. Former Chief Investment Officer and Head of Global Financials at HSBC Asset Management; Founding Director of Accordius; Founding Director of Wallara Asset Management.

Professional photo shoot of woman in black and white

Deborah J. Neff

Non-Executive Director

A veteran of the life sciences industry building market-leading global businesses. As principal of DJN Consulting, LLC. based in the San Francisco Bay Area, Deborah currently works with several privately held healthcare startup companies providing strategic business advice to and mentoring the executive management team. Previously CEO of Evanostics, LLC. and Pathwork Diagnostics Inc., and COO at Complete Genomics Inc., following a 15-year career with Becton Dickinson, Inc. where she last served as President of BDBiosciences, a major global business unit of the company. Former non-executive director of Bio-Rad, Inc., ForteBio, Inc. (acquired by Pall Corp) and AMO Inc., (acquired by Abbott). Deborah served as a board member and executive advisor for Galt Inc., and Vortex Biosciences Inc. She is an Executive Trustee of the UCDavis Foundation Board and also chairs the College of Biological Sciences Dean’s Leadership Council at the University.

Work With Us

Atomo is a fast-growing dynamic company with tremendous opportunities for people interested in revolutionizing healthcare through rapid point-of-care diagnostics.

We’re looking for energetic, creative, entrepreneurial people who have a keen interest in using technology to make the world a better place.

If you would like to join our team, please email careers@atomodiagnostics.com.

Two men in lab coats looking over a document in a laboratory
Smiling woman leaning on the back of a smiling man in an outdoor setting with trees in the background

Re-imagining diagnostics